Carbon Silicon
Venture capitalActively deployingCarson City
Investment thesis
Carbon Silicon Ventures backs founders applying engineering principles and computational methods to biological challenges. The firm focuses on companies developing infrastructure, automation, and AI tools for life sciences, synthetic biology, and biotechnology applications. Portfolio companies span enzymatic DNA synthesis, drug discovery platforms, bioinformatics systems, AI-driven scientific automation, and next-generation therapeutics.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 5 of 11 portfolio companiesBiotech Γ4Deep Tech Γ3AI & Machine Learning Γ2Healthtech Γ2Medical Devices Γ2Cloud Computing Γ1Robotics Γ1SaaS Γ1
HQs:United StatesΓ3
Investments Β· 11 tracked
founders shown can be your intro pathAnsa Biotechnologies develops an enzyme-based process to manufacture DNA, offering an alternative to the established chemical synthesis methods used in the industry. The technology targets research and industrial applications across therapeutics, diagnostics, and biological production.
BiotechHealthtechEmeryville, US
Basepair is a SaaS platform for analyzing and storing genomic data in the cloud, designed for research scientists and bioinformaticians. It provisions into customers' own AWS accounts to manage storage and compute while keeping data in place, eliminating data movement and reducing cloud costs.
BiotechCloud ComputingSaaS
Current Surgical develops a smart needle technology platform for surgical treatment of cancerous tumors. The company serves surgeons and oncologists in the medical device and cancer care space.
Deep TechHealthtechMedical DevicesWashington, US
Medra builds robotic systems integrated with AI, computer vision, and natural language processing to automate data collection for life science research. The company serves biotech and academic research labs seeking high-precision, large-scale experimental data collection.
AI & Machine LearningBiotechDeep TechRobotics
Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.
AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US
Sri Kosuri(Co-founder)
Frequently asked questions
- What sectors does Carbon Silicon focus on?
- Carbon Silicon focuses on AI & Machine Learning, Biotech, Deep Tech.
- Where is Carbon Silicon located?
- Carbon Silicon is headquartered in Carson City, US.
Similar investors
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
Boundary Capital invests in high-growth private technology companies focused on positive impact across life sciences, AI, and engineering sectors.
A research-centric, thesis-driven investment firm that conducts extensive research to develop investment theses across multiple areas and emerging futures.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.